All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2006-003580-31 | A Study of the Efficacy of MORAb-003 in Subjects with Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse | 2010-02-02 | due-trials |
| Reported results | 2007-007633-39 | A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study Of The Efficacy Of MORAb-009 In Combination With Gemcitabine In Patients With Advanced Pancreatic Cancer | 2009-12-16 | due-trials |
| Reported results | 2008-005448-18 | An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma | 2013-12-31 | due-trials |
| Completed, but no date, and reported results Terminated | 2008-005449-43 | A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of MORAb-003 (farletuzumab) in Combination with Paclitaxel Therapy in Subjects with Platinum-Resistant or Refractory Rel... | bad-data | |
| Completed, but no date, and reported results Terminated | 2009-015825-36 | An Open Label Extension Study of the Efficacy of MORAb-003 in Subjects with Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse | bad-data | |
| Reported results | 2010-022229-13 | A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in combination with Carboplatin and Paclitaxel or Docetaxel Followed by Pemetrexed in Chemotherapy na... | 2013-11-01 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2011-001282-40 | A Study of the Efficacy and PK/PD Relationship of Monotherapy MORAb-004 in Subjects with Metastatic Melanoma | 2021-02-25 | bad-data |
| Reported results | 2012-001399-12 | A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma | 2016-02-29 | due-trials |
| Reported results | 2014-003812-36 | A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination with Carboplatin plus Paclitaxel or Carboplatin plus Pegylate... | 2020-08-13 | due-trials |
| Reported results | 2014-004489-85 | A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Pleural Mesothelioma | 2018-11-30 | due-trials |